Stockscreener 앱 받기
29.53
1.57%
-0.47
시장 영업 전:
30.48
0.95
+3.22%
전일 마감가:
$30.00
열려 있는:
$29.75
하루 거래량:
554.71K
Relative Volume:
1.84
시가총액:
$488.36M
수익:
$3.25M
순이익/손실:
$-116.80M
주가수익비율:
-9.682
EPS:
-3.05
순현금흐름:
$-98.17M
1주 성능:
+0.65%
1개월 성능:
+23.30%
6개월 성능:
+322.15%
1년 성능:
+108.55%
1일 변동 폭
$28.86
$30.00
1주일 범위
$25.50
$42.39
52주 변동 폭
$5.6652
$42.39
Rapt Therapeutics Inc Stock (RAPT) Company Profile
명칭
Rapt Therapeutics Inc
전화
(650) 489-9000
주소
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
RAPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
29.53 | 496.13M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-09-26 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-07-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2025-05-22 | 재개 | H.C. Wainwright | Buy |
| 2024-12-26 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-11-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-11-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-21 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | 개시 | Evercore ISI | Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-09-14 | 개시 | Berenberg | Buy |
| 2023-08-09 | 개시 | Stifel | Buy |
| 2023-06-15 | 개시 | Barclays | Overweight |
| 2023-01-04 | 개시 | Guggenheim | Buy |
| 2022-12-01 | 개시 | Goldman | Buy |
| 2022-09-21 | 개시 | CapitalOne | Overweight |
| 2022-05-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-09 | 개시 | JP Morgan | Overweight |
| 2021-08-12 | 개시 | SVB Leerink | Outperform |
| 2021-06-21 | 개시 | Piper Sandler | Overweight |
| 2020-06-01 | 개시 | H.C. Wainwright | Buy |
| 2020-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-04-13 | 개시 | ROTH Capital | Buy |
| 2019-11-25 | 개시 | BMO Capital Markets | Outperform |
| 2019-11-25 | 개시 | UBS | Buy |
| 2019-11-25 | 개시 | Wells Fargo | Outperform |
모두보기
Rapt Therapeutics Inc 주식(RAPT)의 최신 뉴스
What indicators show strength in RAPT Therapeutics Inc.Trade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Published on: 2025-10-27 00:59:41 - newser.com
Can RAPT Therapeutics Inc. recover in the next quarterOptions Play & Daily Growth Stock Tips - newser.com
Risk adjusted return profile for RAPT Therapeutics Inc. analyzedGold Moves & Smart Swing Trading Techniques - newser.com
Analyzing RAPT Therapeutics Inc. with multi timeframe chartsJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-10-26 23:23:14 - newser.com
Is RAPT Therapeutics Inc. stock reversal real or fakeDay Trade & Reliable Breakout Stock Forecasts - newser.com
Does RAPT Therapeutics Inc. (0RA) stock trade below intrinsic valueMarket Activity Recap & Accurate Technical Buy Alerts - newser.com
Published on: 2025-10-26 21:27:10 - newser.com
Why retail investors favor RAPT Therapeutics Inc. stockJuly 2025 Short Interest & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-26 20:42:00 - newser.com
Is RAPT Therapeutics Inc. stock a buy for dividend growthJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Why RAPT Therapeutics Inc. (0RA) stock could break out in 2025Quarterly Earnings Report & Technical Entry and Exit Alerts - newser.com
Published on: 2025-10-26 15:06:18 - newser.com
Tick level data insight on RAPT Therapeutics Inc. volatility2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Leading vs lagging indicators on RAPT Therapeutics Inc. performanceInsider Selling & Technical Entry and Exit Tips - newser.com
Published on: 2025-10-26 10:44:52 - newser.com
Wells Fargo Boosts RAPT Therapeutics (RAPT) PT to $48 on Promising Anti-IgE Drug Data - Insider Monkey
Published on: 2025-10-26 00:53:27 - newser.com
Published on: 2025-10-25 21:57:06 - newser.com
Rapt Therapeutics Inc (RAPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
0.29%
자본화:
|
볼륨(24시간):